Patient Journey and Experiences

Study provides patient perspectives on the debilitating nature of amyloidosis and reveals a delay from symptom onset to diagnosis of >2 years. Read More ›

For the patients interviewed, the impacts of hereditary transthyretin amyloidosis were profound. Read More ›


The high variability in clinical manifestations of cardiac amyloidosis can lead to delays between symptom onset and correct diagnosis. Read More ›

Educating clinicians about transthyretin amyloidosis (ATTR) may help reduce the myriad of challenges and burdens faced by patients with ATTR and their families. Read More ›

Subscribe to Amyloidosis News

Stay up to date with Amyloidosis News & updates by subscribing to receive the free AMN e‑Newsletter.